Industry leader and multi-omics pioneer joins leadership team to advance AI-driven solutions
Gent, Belgium – 17th November, 2025. BioLizard, a leader in multi-omics integration and AI-powered biopharma analytics, is pleased to announce the appointment of Dr. Alexander Scheer as Chief Scientific Officer (CSO). Dr. Scheer is a highly respected...
BioLizard Logs Stellar First Half of 2025: Growth, Innovation & Recognition
As we gear up for the final stretch of the year, BioLizard enters the autumn season with renewed energy and momentum. The company has delivered a standout first half of 2025, marked by international recognition, groundbreaking AI innovation, and strategic expansion....
BioLizard Awarded Grant from VLAIO to Advance AI-Powered Biomedical Solution for Accelerated Drug Development
VLAIO grant to fund development of new AI application, using large language models (LLMs) to search, extract and structure key insights from vast scientific datasets, significantly reducing review time and knowledge extraction State-of-the-art solution will further...
BioLizard Launches Bio|Verse® Navigator for Easy Exploration of Complex Biomedical Data
Bio|Verse Navigator can accelerate data exploration and interpretation workflows multifold, reducing time-to-insight for researchers. The application combines advanced BioLizard’s bioinformatics expertise in handling various customer datasets with powerful visual...